Clinical Trials Logo

Coronary Disease clinical trials

View clinical trials related to Coronary Disease.

Filter by:

NCT ID: NCT01386021 Completed - Clinical trials for Coronary Artery Disease

Saphenous Vein Allografts for Coronary Bypass

Start date: June 2011
Phase: N/A
Study type: Observational

The primary objective of this observational study is to evaluate the function (patency) of cryopreserved saphenous vein allografts used as coronary artery bypass grafts (CABG) for patients with occlusive coronary artery disease.

NCT ID: NCT01384448 Completed - Clinical trials for Coronary Artery Disease

Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain

Start date: August 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether stress echocardiography or computed tomography (CT) of the heart is better at diagnosing emergency room chest pain patients to select appropriate candidates for hospitalization and further work-up.

NCT ID: NCT01384175 Completed - Clinical trials for Coronary Artery Disease

Epidural Anesthesia and Postoperative Analgesia With Ropivacaine and Fentanyl

Start date: January 2008
Phase: N/A
Study type: Interventional

The aim of the present study was to assess the efficacy of thoracic epidural anesthesia followed by postoperative epidural infusion and patient-controlled epidural analgesia with ropivacaine/fentanyl in off-pump coronary artery bypass grafting

NCT ID: NCT01380821 Completed - Clinical trials for Coronary Artery Disease

DNA Double-strand Breaks After SPECT

DSB-SPECT
Start date: March 2011
Phase: N/A
Study type: Observational

Ionizing radiation has a number of harmful effects in humans. The most important among these is the induction of cancer. It is assumed that damage to DNA in the nucleus of a single cell can induce cancer. Among the different types of lesions inducted, DNA double-strand breaks (DSBs) are considered to be the most relevant effects that can initiate carcinogenesis. The investigators are already conducting several other studies to prospectively compare the inducted DSBs by coronary CT-angiography and conventional coronary angiography. Extending these examinations to investigate the induced DSBs by myocardial scintigraphy allows a comparison of all three relevant imaging methods of the heart that incorporate ionizing radiation. To evaluate this, the investigators are planning to examine patients who are scheduled for a clinically indicated myocardial scintigraphy. These examinations are routinely done by the Department of Nuclear Medicine in either a 1-day or a 2-day protocol according to the diagnostic reference values of the Federal Department for Radiological Protection. Blood samples will be taken from these patients at predefined time steps before and after the examination and DNA double-strand breaks will be determined from these blood samples specifically considering the applied activity of the tracer and the exposition kinetics.

NCT ID: NCT01379677 Completed - Clinical trials for Coronary Artery Disease

Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

Start date: February 2011
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to compare myocardial perfusion imaging using Rubidium-82 PET with Tc-99m-MIBI SPET, in the evaluation of significant Coronary Artery Disease (CAD).

NCT ID: NCT01379131 Completed - Clinical trials for Myocardial Infarction

Previous Cardiovascular Disease, Cardiovascular Risk Factors and Chest Pain in First Myocardial Infarction

Start date: September 2009
Phase: N/A
Study type: Observational

Some myocardial infarctions (MI) occur as the first manifestation of atherosclerotic disease. Such MIs are important because of the high likelihood of missed opportunities for prevention. A recent analysis using CALIBER data estimated this proportion at 60%. Further to this research, another level of complexity can be added to improve our understanding of these MIs. This is the concept of a completely 'unanticipated' MI, which can be defined as: MI occurring as the first manifestation of atherosclerotic disease and without any traditional cardiovascular risk factors and without any prior chest pain. Such 'unanticipated' MIs cannot be foreseen by the medical profession and their frequency in the population is unknown. Therefore the aim of this study is to describe the distribution of previously diagnosed cardiovascular disease, cardiovascular risk factors and chest pain in patients with first MI. This will provide an estimate of the number of 'unanticipated' MIs and of the levels of risk factors in unheralded, compared to heralded MI.

NCT ID: NCT01377402 Completed - Clinical trials for Coronary Artery Disease

ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study

ARRA-RACS
Start date: November 2005
Phase: N/A
Study type: Observational

The first aim of this trial is to assess the long-term prognostic value of Omega-3 index, which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane, in an unselected, regional multicenter observational study of 982 chest pain patients admitted to the emergency unit, employing blood samples collected at admission. The second purpose of this study is to evaluate the prognostic utility of vitamin D in the same population. The third purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).

NCT ID: NCT01373944 Completed - Clinical trials for Coronary Artery Disease

Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI

Start date: May 2010
Phase: N/A
Study type: Observational

The purpose of this study is to compare clinical efficiency and patient outcomes using ultra low-dose stress only Tc-99m and solid-state SPECT versus traditional Anger SPECT.

NCT ID: NCT01373645 Completed - Clinical trials for Coronary Artery Disease

Safety and Efficacy Registry of Yinyi Stent

SERY-I
Start date: January 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and delayed restenosis. Persistent polymer could be responsible. Local delivery of paclitxel from a polymer-free Yinyi stent (Dalian Yinyi biomaterial research and development co.ltd) may prevent these complications.

NCT ID: NCT01373411 Completed - Clinical trials for Coronary Artery Disease

Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery

TAP-CABG
Start date: September 2011
Phase: Phase 4
Study type: Interventional

Subjects will be consented to the study prior to Coronary Artery Bypass Graft (CABG) and randomly assigned to receive either ticagrelor 90 mg bid or placebo bid starting within 48 hours of surgery. Subjects will remain on study drug for a minimum of 12 months during which time they will receive telephone follow-up one and nine months following CABG and clinic visits three, six, and twelve months following CABG.